Specify a stock or a cryptocurrency in the search bar to get a summary
Rohto Pharmaceutical Co.Ltd.
4527Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan. Address: 1-8-1, Tatsumi-nishi, Osaka, Japan, 544-8666
Analytics
WallStreet Target Price
643 777.75 JPYP/E ratio
20.6525Dividend Yield
1.2 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4527
Dividend Analytics 4527
Dividend growth over 5 years
118 %Continuous growth
4 yearsPayout Ratio 5 years average
19 %Dividend History 4527
Stock Valuation 4527
Financials 4527
Results | 2019 | Dynamics |